Gilead Sciences, Inc.
Long

GILD - Still long..

121
Clear low risk set-up. Not quite as profitable (so far) as NVAX / MRNA.. But the chart says it all.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.